Can psychedelics improve well-being in autism?

Summary

Emerging evidence suggests psychedelic therapies may help reduce anxiety and enhance social connection in autistic adults. Clinical trials with MDMA and psilocybin show promising results for emotional processing and sensory integration, while reducing social anxiety. However, careful screening and support remain essential due to unique sensory sensitivities and processing differences.

Abstract

A brace of new studies probes benefits and risks for an understudied group.

Tags